Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Julphar
Express Scripts
Covington
Baxter
Moodys
Accenture
Teva
Chinese Patent Office

Generated: October 16, 2017

DrugPatentWatch Database Preview

VIRACEPT Drug Profile

« Back to Dashboard

What is the patent landscape for Viracept, and when can generic versions of Viracept launch?

Viracept is a drug marketed by Agouron Pharms and is included in three NDAs.

The generic ingredient in VIRACEPT is nelfinavir mesylate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nelfinavir mesylate profile page.

Summary for Tradename: VIRACEPT

US Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list63
Clinical Trials: see list40
Patent Applications: see list2,170
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VIRACEPT at DailyMed

Pharmacology for Tradename: VIRACEPT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003RXYesYes► Subscribe► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Johnson and Johnson
Cerilliant
Daiichi Sankyo
Merck
Chinese Patent Office
Mallinckrodt
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot